Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion type Assertion NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_head.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion description "[Our results showed that the IGFBP2/FAK pathway is causally associated with dasatinib resistance and may be used as biomarkers for identification of dasatinib responders among patients with lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion evidence source_evidence_literature NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion SIO_000772 24130049 NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion wasDerivedFrom befree-2016 NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.
- NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_assertion wasGeneratedBy ECO_0000203 NP1119699.RAE2z8bRpq2r0UExVcFYq1cU8_rjQkXr25LfntNvQWuuY130_provenance.